Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-07-24 | Ziccum | Ziccum säkrar andra Feasibility-avtalet på två månader: VD-intervju på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-20 | Ziccum | Ziccums Q2-rapport - VD-uppdatering på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-18 | Ziccum | ZICCUM AB (publ) Interim report Q2 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-07-17 | Ziccum | Ziccum signs Evaluation Agreement for Feasibility Study with major global Pharmaceutical Corporation | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-19 | Ziccum | Ziccum sponsors the Global mRNA-Based Therapeutics Summit, Boston MA, July 26-28 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-05 | Ziccum | Ziccum joint proposal not selected for detailed application in current CEPI Call | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-02 | Ziccum | Ziccum appoints senior biopharma executive as new CFO | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-30 | Ziccum | Ziccum AB: BioStock Life Science Spring Summit med Ziccum | Pressreleaser | Visa Stäng |
|
||||
2023-05-30 | Ziccum | Ziccum AB: BioStock Life Science Spring Summit with Ziccum | Pressreleaser | Visa Stäng |
|
||||
2023-05-26 | Ziccum | Aerosol and inhalation authority Per Gerde joins Board of Directors of Ziccum AB | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Aerosol and inhalation authority Per Gerde joins Board of Directors of Ziccum ABNew Ziccum Board member Assoc. Prof. Per Gerde has over 55 peer-reviewed scientific papers and six patent families to his name. He is the original inventor of Ziccum’s drying technology for pharmaceuticals, LaminarPace, and an authority on aerosol exposure technologies and inhalation toxicology. “Per brings decades of industry expertise to our Board, as well as his background knowledge of LaminarPace” says Ziccum Chairman Fredrik Sjövall, “we are delighted to welcome him”. Per Gerde is Associate Professor of Inhalation Toxicology at the Division of Physiology, Institute of Environmental Medicine at Karolinska Institutet (retired, but remains associated), and the founder in 2004 of Inhalation Sciences AB (ISAB), Ziccum’s original parent company, for whom he remains CSO. Gerde is a recognized authority in inhalation research and development and inhalation toxicology. His previous roles include research scientist at the Swedish National Institute of Occupational Health and postdoctoral fellow and visiting scientist at the influential Lovelace Respiratory Research Institute in New Mexico, USA. He is a Key opinion leader within inhalation and is the inventor of ISAB’s precision aerosol generation system PreciseInhale, which is installed at development and research facilities in Europe, the US and Asia. Ziccum’s’ pharmaceutical drying system LaminarPace was first developed by Assoc. Prof. Gerde to generate dry powder micronized particles suitable for aerosolization in PreciseInhale. As LaminarPace’s unique ability to deliver dried, thermostable particles of even delicate biologics and biopharmaceuticals emerged, Inhalation Sciences decided to spin the technology out, in 2017, into the subsidiary Ziccum AB. Today’s LaminarPace is the fourth generation, with extensive development work completed towards its scale out as a unique unit of pharmaceutical production, including advanced 3D modeling being carried out in partnership with the ICP Institute of Computational Physics at the Zurich University of Applied Sciences’s School of Engineering (ZHAW). Assoc. Prof. Per Gerde: “I am pleased and excited to be involved again with LaminarPace. The technological development and progress Ziccum has made in advancing the system from its early iterations is impressive and exciting. I am very happy to see the extent of that progress, and to be able to return to and contribute once more towards the system’s development, as a Board member. I look forward to working with the Ziccum team”. Ziccum Chairman of the Board Fredrik Sjövall: “Per brings decades of industry expertise and wisdom to our Board of Directors, as well as his significant background knowledge of LaminarPace. His expertise and commitment to developing successful new systems that add new value to their sector is powerful and proven. We are delighted to welcome him to the Board”. |
||||
2023-05-25 | Ziccum | Ziccum CEO to present at BioStock Life Science Spring Summit | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | Ziccum | Kommuniké från årsstämma i Ziccum AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | Ziccum | Bulletin from the Annual General Meeting of Ziccum AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-11 | Ziccum | Strategin ger resultat med betald studie i samarbete med toppbolag: VD-intervju på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-09 | Ziccum | Ziccum signs Evaluation Agreement with Biopharmaceutical Corporation focused on mRNA technologies | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-09 | Ziccum | Ziccums Q1-resultat: VD-uppdatering på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-08 | Ziccum | KOMPLETTERING TILL KALLELSEN TILL ÅRSSTÄMMA I ZICCUM AB (PUBL), ATT HÅLLAS DEN 24 MAJ 2023, KL. 11.00 I BOLAGETS LOKALER PÅ SCHEELEVÄGEN 22 I LUND | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-02 | Ziccum | Ziccum AB filing three patent applications as part of new, expanded strategy to strengthen patent protection | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-26 | Ziccum | ZICCUM AB (publ) releases Interim report Q1 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-24 | Ziccum | KALLELSE TILL ÅRSSTÄMMA I ZICCUM AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-20 | Ziccum | Ziccum reports positive results from drying of active mRNA and promising mRNA activity after powder reconstitution | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-17 | Ziccum | Ziccum to attend BIO-Europe Spring in Basel | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-10 | Ziccum | Ziccum AB joins innovative financial platform for Investor Relations management and European outreach | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-17 | Ziccum | ZICCUM AB (publ) releases Annual Report 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-01-27 | Ziccum | ZICCUM AB (publ) Year-end report Q4 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-23 | Ziccum | Ziccum submits Expression of Interest for CEPI funding | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-18 | Ziccum | Ziccum CEO to present at international mRNA Summit in Berlin | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-16 | Ziccum | Ziccum awarded 10 MSEK Eurostars funding for 3D-modeling and Digital twin project | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-14 | Ziccum | Ziccum launches new, expanded website | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-08 | Ziccum | Ziccum signs agreement with Zurich University of Applied Sciences on advanced 3D-modeling project | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-28 | Ziccum | Ziccums Q3-resultat: VD-uppdatering på svenska | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-27 | Ziccum | ZICCUM AB (publ) Interim report Q3 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-24 | Ziccum | Ziccum generates proof of successful drying of lipid nanoparticles in mRNA project | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-27 | Ziccum | Ziccum reopens application for CEPI funding on thermostable vaccines with new partner | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-23 | Ziccum | Ziccum receives results from evaluation study with leading Pharmaceutical Corporation | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-14 | Ziccum | Ziccum and Zurich University of Applied Sciences submit joint application for Eurostars funding | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-01 | Ziccum | Ziccum on the move: company to attend major industry events across Europe in 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-23 | Ziccum | ZICCUM AB (publ) Interim report Q2 2022 | Analyser | Ladda ner | Visa Stäng |
|